Please provide your email address to receive an email when new articles are posted on . Risk factors for patients with acute MI have changed modestly as treatment has improved, with mortality rates ...

"So that led to much higher mortality rates than seen in previous studies," Roe added. Unadjusted in-hospital mortality rates were 12.5% for non-STEMI patients and 14.3% for STEMI patients (p<0.001).

Please provide your email address to receive an email when new articles are posted on . Heart attacks, both STEMI and non-STEMI, declined less for men vs. women from 2011 to 2018. Women received ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ATLANTA -- ...

SAN FRANCISCO -- For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, there was no clinical benefit to a strategy of finding and treating all nonculprit ...

Within five days of the myocardial infarction, 1,601 patients aged 45 years and older were randomly allocated to asundexian 10 mg, 20 mg, 50 mg or placebo, with approximately 400 patients in each ...

Income-based disparities in the care and outcomes experienced by patients with acute myocardial infarction (MI) are seen around the world, despite vastly different healthcare and social safety net ...

The benefits of complete revascularization over culprit-only coronary artery revascularisation were confirmed in older patients with ST-segment elevation myocardial infarction (STEMI) and multivessel ...